Dishman Pharma Q1 profit jumps 58.4% on strong EBITDA

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Moneycontrol Bureau

Dishman Pharmaceuticals & Chemicals' first quarter (April-June) consolidated net profit climbed 58.4 percent to Rs 37.7 crore compared to Rs 23.8 crore in the year-ago period, driven by strong operational performance.

Total income from operations grew by 10.4 percent to Rs 400.5 crore during the quarter compared to Rs 362.7 crore in same quarter last year.

Operating profit (earnings before interest, tax, depreciation and amortisation) shot up 38.4 percent on yearly basis to Rs 104 crore and margin expanded by 530 basis points to 26.1 percent in the quarter ended June.

Revenue from its contract research and manufacturing segment increased by 5.2 percent year-on-year to Rs 251.9 crore with EBIT (earnings before interest and tax) up 33.8 percent while revenue from other businesses (bulk drugs, intermediates quats, speciality chemicals and traded goods) rose by 21.3 percent to Rs 148 crore with EBIT growth of 187 percent.

At 15:05 hours IST, the scrip of Dishman Pharmaceuticals & Chemicals was quoting at Rs 214.50, up Rs 4.60, or 2.19 percent on the BSE.Posted by Sunil Shankar Matkar